• Clasto-Lactacystin β-lactone in Proteasome Assays

  2026-08-18

  Clasto-Lactacystin β-lactone enables controlled, cell-based interrogation of proteasome-dependent protein turnover, from pulse-chase experiments to viral inflammation models. This workflow-oriented guide shows how to connect proteasome inhibition assay data with RIPK3 degradation, necroptosis, cancer research, and disease-model readouts while avoiding common interpretation errors.

• MLN4924: NEDD8 Pathway Workflow

  2026-08-17

  MLN4924 enables controlled inhibition of the NEDD8-activating enzyme to connect pathway biochemistry with cell-cycle, apoptosis, and protein-degradation phenotypes. This practical guide distinguishes broad NAE blockade from downstream UBE2F–CRL5 targeting and provides assay-ready optimization and troubleshooting strategies.

• ITGA3/FAK/YAP Dysfunction in COPD Alveoli

  2026-08-17

  The reference study identifies loss of ITGA3 and dysregulation of the FAK/YAP pathway as a mechanistic link between cigarette smoke-associated oxidative stress and impaired alveolar type II cell regeneration in COPD. By combining patient material, a chronic smoke-exposure model, and alveolar organoids, the work positions ITGA3 as a potential target for restoring AT2 cell stemness, while also defining important limits for translating pathway-modulating tools into pulmonary research.

• Aconitase Activity Colorimetric Assay Kit Guide

  2026-08-16

  The Aconitase Activity Colorimetric Assay Kit provides a practical readout of TCA-cycle integrity that complements studies of CD8+ T-cell metabolic flexibility. This guide explains how K2226 distinguishes glycolytic adaptation from mitochondrial iron-sulfur damage and supports oxidative damage measurement.

• Aconitase Activity Colorimetric Assay Kit

  2026-08-15

  A practical, scenario-driven guide to using Aconitase Activity Colorimetric Assay Kit SKU K2226 for TCA-cycle, oxidative-stress, and immunometabolic studies. It explains assay principles, controls, protocol decisions, interpretation, and vendor-selection criteria without overstating unsupported performance claims.

• TH287 Radiosensitizes Castration-Resistant Prostate Cancer

  2026-08-14

  The reference study shows that TH287, an MTH1 inhibitor, increases the susceptibility of PC-3 and DU-145 castration-resistant prostate cancer cells to ionizing radiation, with the strongest combination effect when radiation follows drug exposure by 12 hours. Its value lies in defining a practical treatment sequence and linking MTH1 inhibition with enhanced apoptosis and cell-cycle disruption, although the evidence remains limited to in vitro models.

• Bufalin–CRISPR Nanomedicine for Colorectal Cancer

  2026-08-14

  Liu et al. developed calcium lactate nanoparticles that co-deliver bufalin and CRISPR/Cas9 ribonucleoproteins targeting CD47, linking tumor-cell death with macrophage reprogramming. The study presents a multimodal strategy in which pyroptosis, apoptosis, reduced antiphagocytic signaling, and M1-like macrophage activation cooperate to strengthen local and systemic antitumor immunity.

• Biomimetic Chromatography for Lung Permeability

  2026-08-13

  The reference study evaluates immobilised artificial membrane liquid chromatography and open-tubular capillary electrochromatography, both coupled with mass spectrometry, as biomimetic models of pulmonary drug permeability. Its comparison of 53 structurally diverse compounds shows that IAM-LC provides stronger links to partitioning and apparent permeability, whereas OT-CEC adds complementary information about phospholipid composition and drug–membrane interactions.

• Clasto-Lactacystin β-lactone Assay Guide

  2026-08-13

  A scenario-based guide to using Clasto-Lactacystin β-lactone (SKU A2578) in viability, proliferation, cytotoxicity, and proteasome inhibition workflows. It explains experimental controls, formulation and storage decisions, interpretation of irreversible proteasome inhibition, and practical vendor-selection criteria.

• Myotubularin 2 Controls Autophagy at Arabidopsis ERES

  2026-08-12

  This study identifies Arabidopsis Myotubularin 2 (MTM2) as a phosphatidylinositol 3-phosphate phosphatase that localizes to ER exit sites and restrains autophagy. By connecting MTM2 to SEC23A and COPII-dependent secretion, the work reveals how local phosphoinositide turnover coordinates autophagosome formation, protein export, and salt-stress adaptation.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-08-12

  The reference study identifies circulating moesin (MSN) as a candidate indicator of endothelial injury and sepsis severity, linking serum levels with SOFA scores, procalcitonin, and experimental lung damage. Its combination of patient measurements, mouse sepsis models, and endothelial-cell mechanistic experiments supports MSN as both a biomarker candidate and a mediator of barrier dysfunction, while leaving diagnostic validation and therapeutic translation for future work.

• MLN4924: Selective NEDD8-Activating Enzyme Inhibitor

  2026-08-11

  MLN4924 is a selective NEDD8-activating enzyme inhibitor that blocks neddylation, suppresses cullin-RING ligase activity, and promotes accumulation of CRL substrates such as CDT1. Its biochemical potency, xenograft activity, and solvent-specific handling profile make it a useful tool for cancer biology research.

• Crizotinib hydrochloride: Assay Reliability

  2026-08-11

  Learn how Crizotinib hydrochloride, SKU B3608, supports reproducible viability and signaling studies in ALK-, c-MET-, and ROS1-relevant models. This scenario-driven guide connects compound handling, assembloid design, pathway validation, and practical vendor selection to evidence from recent cancer research.

• Mechanistic Classification of Aneugenic Chemicals

  2026-08-10

  The reference study presents a tiered flow-cytometric strategy that distinguishes tubulin destabilization, tubulin stabilization, and mitotic kinase inhibition among aneugenic chemicals. Tested against 27 reference compounds, the workflow combined biomarker profiling with 488-Taxol and p-H3:Ki-67 responses, enabling an artificial neural network to predict molecular targets with 25/26 leave-one-out agreement.

• EGTA: Precision Calcium Chelation in Cell Models

  2026-08-09

  EGTA, also called egtazic acid, is an aminopolycarboxylic acid used to reduce free calcium in biochemical and cellular experiments. B7195 is a 98% pure EGTA product intended for calcium signaling, neuroprotection, and endothelial inflammation workflows, but its limited solubility requires careful preparation.

8514 records 2/568 page Previous Next 12345 下5页 Last page